Physician profile
Henry C Waterer
NPI 1326064601
$12,599.58
in general payments reported to CMS, 2019-2025
46 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,626 · 2020: $1,257 · 2021: $1,657 · 2022: $2,398 · 2023: $1,942 · 2024: $2,272 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,662.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,123.24 | 2019-2024 | Impella |
| Medtronic, INC. | $1,405.48 | 2021-2025 | Symplicity G3, Onyx Frontier, Micra |
| Novartis Pharmaceuticals Corporation | $1,108.23 | 2019-2025 | |
| Abbott Laboratories | $820.83 | 2019-2024 | Gallant |
| Boston Scientific Corporation | $685.51 | 2019-2025 | Watchman Access System, Farapulse, Rhythmia Mapping System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $647.58 | 2021-2025 | Jardiance |
| Edwards Lifesciences Corporation | $600.17 | 2019-2022 | |
| Inari Medical, INC. | $525.14 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $429.04 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $384.31 | 2022-2025 | Verquvo, Capvaxive, Keytruda |
| Penumbra, INC. | $371.43 | 2020-2024 | Indigo System |
| Philips North America LLC | $317.41 | 2019-2025 | Lm Undivided, (6571) Eagle Eye |
| Inspire Medical Systems, INC. | $285.64 | 2023-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $282.05 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $273.59 | 2020-2024 | Wainua |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $220.66 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $219.86 | 2024-2025 | Wegovy |
| Amgen INC. | $201.60 | 2019-2023 | Repatha |
| Irhythm Technologies, INC. | $183.74 | 2019-2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $162.84 | 2021-2025 | |
| Heartflow, INC. | $159.50 | 2023 | Ffrct |
| Acist Medical Systems, INC. | $149.45 | 2023 | |
| Cvrx, INC. | $145.57 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $115.72 | 2019-2025 | Amvuttra |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Ekos Corporation | $100.16 | 2019 | |
| Braemar Manufacturing, LLC | $64.16 | 2019 | |
| Medtronic Vascular, INC. | $57.25 | 2020 | |
| Chiesi USA, INC. | $52.82 | 2023-2025 | Cleviprex, Kengreal |
| W. L. Gore & Associates, INC. | $51.12 | 2021 | |
| Bridgebio Pharma, INC. | $35.09 | 2025 | Attruby |
| Terumo Medical Corporation | $32.89 | 2021 | |
| Teleflex LLC | $32.13 | 2023 | Manta |
| Shockwave Medical, INC | $29.39 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Akcea Therapeutics, INC. | $27.20 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $23.52 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $21.31 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.01 | 2019-2024 | Lifevest |
| Convatec INC. | $20.26 | 2025 | |
| Esperion Therapeutics, INC. | $19.33 | 2021 | |
| Stryker Corporation | $16.46 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $15.42 | 2019 | |
| Glaxosmithkline, LLC. | $15.16 | 2025 | Shingrix, Arexvy |
| Actelion Pharmaceuticals US, INC. | $13.55 | 2023 | Uptravi, Opsumit |
| Arbor Pharmaceuticals, INC. | $12.77 | 2019 | |
| Gilead Sciences, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Waterer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.